Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Minimally Invasive Suprachoroidal Drainage for the Treatment of Advanced Neovascular Glaucoma

NCT07882511 is registered in ClinicalTrials.gov with Zhongnan Hospital as lead sponsor.

NCT NCT07882511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07882511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Minimally Invasive Suprachoroidal Drainage for the Treatment of Advanced Neovascular Glaucoma
Lead sponsor
Zhongnan Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2024
Completion date
April 30, 2026
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular glaucoma